Archives for June 2008

A Judicial Watch Special Report on Gardasil

A Judicial Watch Special Report Examining the FDA’s HPV Vaccine Records Detailing the Approval Process, Side-Effects, Safety Concerns and Marketing Practices of a Large-Scale Public Health Experiment June 30, 2008 Pg. 8 The significant differences between the saline placebo and the vaccine raisequestions as to how Merck’s use of an aluminum-containing placebo may Continue Reading …

A Judicial Watch Special Report on Gardasil

A Judicial Watch Special Report Examining the FDA’s HPV Vaccine Records Detailing the Approval Process, Side-Effects, Safety Concerns and Marketing Practices of a Large-Scale Public Health Experiment June 30, 2008 Judicial Watch Special Report: Page 1 of 24 Introduction This Judicial Watch Special Report is an analysis of records obtained from Continue Reading …

Coffee benefits your health and protects against many diseases.

Why is there resistance to the idea that coffee benefits your health? Here’s why. Almost thirty years ago researchers at Harvard University announced a connection between coffee consumption and cancer. A few years later they retracted the study and recognized that the findings were flawed. However, since that first study and the media frenzy that Continue Reading …

FDA Thwarts Merck’s Expanded Use of Gardasil, For Now

The FDA rejected Merck’s request to approve its HPV vaccine, Gardasil for women between ages 27 and 45, citing “issues that preclude approval within the expected review timeframe,” Merck offered no additional specific explanation in their prepared statement. Merck indicated that it is in ongoing discussions with FDA officials about to the application and expects to officially respond to the agency within the next 30-days. The HPV- vaccine, Gardasil, was approved June 8, 2006 for girls and women between 9 and 26 years old to prevent human papillomarivus related cervical cancer.

U.S. Employers Pushing Women Out of Work Force

Baby Boom — All Over Again NEW YORK (WOMENSENEWS)-As Lisa Seftel was planning for her first child, she thought she had struck a good deal with her boss. After the baby came, she’d work three days managing a family-owned consultancy’s Manhattan headquarters and two days at home in a New York suburb. This would give Continue Reading …

Cash Bombs Fall on Canadian Officials as Merck Marketing Blitzkrieg Moves North

Is the HPV vaccine a victory for women’s health or the triumph of aggressive marketing? Canadian reporters struggle to shed light on a muddled debate that’s as much about business as it is about health. When federal Finance Minister Jim Flaherty announced $300 million in funding for a program to vaccinate girls and young women Continue Reading …

Avoid Legalized Drug Pushers…Take Back Control of Your Body With Proactive Nutrition

The Top Ten Anti Cancer Foods Rushing out the door to work, you grab yourself a bag lunch: a soy-make-believe-turkey sandwich on whole wheat, salad with a little bit of dressing, a handful of walnuts, and two tangerines. A healthy meal you think. More than healthy: As a matter of fact, researchers believe that those Continue Reading …

Don't Let Congress Take Your Vitamins Away!

In 1994, Congress passed the Dietary Supplement Health and Education Act (DSHEA). The passage of DSHEA witnessed the biggest victory for consumers in the history of Congress. More letters were written to Congress than on any other piece of legislation in the history of our country. The voice of the people spoke louder on dietary Continue Reading …

Big Fat Pharma Liars

Industry attacks supplements to eliminate weight-loss competition. Big Pharma is at it again, this time teaming up with other anti-supplement cohorts to spearhead a petition that urges the Food and Drug Administration (FDA) to implement stringent new limitations on manufacturers of weight-management supplements. Of course, it should come as no surprise that the particular large Continue Reading …

BBC Reports Glaxo's Very Profitable HPV Vaccine Contract With UK

BBC story diagrams the corporate infighting over which multi-national Pharma Giant wins the very profitable HPV vaccine contract with the UK public health department. Glaxo needed a win big time. Merck has effectively shut them out of the lucrative American market, (the paper work has the FDA logo, but in the ‘Mercky’ world of vaccine politics, Merck lobbyists know how to deliver…a politician, regulator, or an agency, Merck Money moves opinion and decisions.) Merck won’t stop fighting to get a piece of the UK school girl market. Expect continuous stream of Merck public relations rhetoric throughout the balance of 2008 and up to the International Human Papilloma Virus Conference, held in Sweden next June. Both Merck and Glaxo are scheduled to deliver papers. In the Merck world view, “Its not over, until it is over.”